BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Cell Science

About Cell Science

CEL-SCI Corporation is a biotechnology company engaged in research and development of drugs and vaccines. CEL-SCI's most advanced product is Multikine® , an immunotherapeutic agent consisting of a mixture of naturally occurring cytokines including interleukins, interferons, chemokines and colony-stimulating factors. Multikine, manufactured using the company's proprietary cell culture technologies, is being developed for the treatment of cancer. The lead indication is advanced, primary head & neck cancer (500,000 new cases per annum), the second indication is cervical dysplasia (2 million cases per annum in U.S. alone).

 

Products

 

More on Cell Science


Home Page for Cell Science

Key Statistics for Cell Science

Basic Chart for Cell Science

Analyst Opinion

Analysts Estimates

News on Cell Science

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com